Canada: Patent

Subscribe

Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.

Coup d'œil sur les nouvelles règles de PIO concernant le financement des services juridiques en PI pour les entreprises de l'Ontario

En réponse directe aux commentaires reçus et à l'évolution des besoins des entreprises d'innovation de l'Ontario en matière de propriété intellectuelle, Propriété intellectuelle Ontario (PIO) a annoncé deux...

MT

Miller Thomson LLP

Canadian Patent Law: A Board Assesses Patentability While The Court Assesses Validity

In the recent decision of Zacon Limited v Provincial Doors Inc et al, 2025 ONSC 2954 (the "Court's Decision"), the Ontario Superior Court of Justice (the "ONSC") found that, under the Patent...

ML

McMillan LLP

Patents vs Trade Secrets In Canada – No, They're Not Just Alternatives

As an intellectual property lawyer and patent agent, I am regularly approached by clients or prospective clients who want to know if they should protect their new widget with either (a) a patent or (b) a trade secret.

PL

Procido LLP

Inventorship And The Importance Of Invention Documentation

Inventors, patent applicants, and patent assignees should carefully consider who the actual inventors of their patents are, or they may risk losing their patent rights altogether.

OW

Oyen Wiggs Green & Mutala LLP

What The Canuck?! Understanding Scandalous, Obscene And Immoral Marks In Canada

SB

Smart & Biggar

Tariffs And Counterfeits - A Silver Lining?

DW

Deeth Williams Wall LLP

Québec's New Language Law Changes: Is Your Business Compliant?

BL

Borden Ladner Gervais LLP

Random Trademark Summary Cancellation Proceedings In Canada: What You Need To Know

GW

Gowling WLG

Canadian Intellectual Property Office "Next Generation Patents" Update And Status As Of June 17, 2025

SB

Smart & Biggar

Potential Amendments To Canadian Practice On Patentable Subject-Matter For Computer-Implemented Inventions

C

Cassels

TMOB Refuses Application On Descriptiveness And Non-Use Grounds

OW

Oyen Wiggs Green & Mutala LLP

Trademarks En Français: Navigating Québec's Language Laws

D

Dentons

Incidence de l'IA sur le droit canadien

BC

Blake, Cassels & Graydon LLP

CIPO Releases Practice Notice Regarding The Use Of AI In Proceedings Before The TMOB

OW

Oyen Wiggs Green & Mutala LLP

Changes To Canada's C11 Work Permit In 2025: What Matters And How To Win .

Canada Immigration

S

Sobirovs Law Firm

Don't Use Severance As Leverage: Courts Are Not Impressed

Canada Employment

SL

Spring Law

Lease Termination Clauses: Know The Target Before Pulling The Trigger

Canada Real Estate

BJ

Bennett Jones LLP

Mental Health Accommodation Policies And Procedures In The Workplace: Practical Guidance For Employers

Canada Employment

BL

Borden Ladner Gervais LLP

Re-Paving The Process: Bill C-5's Impact On Major Project Approvals And Mobility

Canada Government

ML

McMillan LLP

Related Country Guides

Trademark Disputes

Patent Litigation

Biotech, Life Sciences & Healthcare

Genentech And U Penn Settle HERCEPTIN Patent Suit

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

BR

Beeser Ramamoorthy LLP

Subsequent-Entry Biologic Patent Litigation Commences In Canada

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

SB

Smart & Biggar

Pharma In Brief - Canada: Federal Court Reduces Claim For Section 8 Damages Based On Defence Of Ex Turpi Causa [MEVACOR® (lovastatin)]

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

Canada Healthcare

NR

Norton Rose Fulbright Canada LLP

DIP Working Group Recommends That PMPRB Permanently Adopt The DIP Methodology

Canada Healthcare

F

Fasken

Pharma In Brief - Canada: Federal Court Releases Decisions In Ramipril Section 8 Cases

Canada Healthcare

NR

Norton Rose Fulbright Canada LLP

Section 8 Proceedings - Damages Awarded And Quantified (Intellectual Property Weekly Abstracts Bulletin - Week Of May 7, 2012)

BL

Borden Ladner Gervais LLP

U.S. Appeals Court Overturns District Court's Finding Of Obviousness (AMRIX/Cyclobenzaprine Hydrochloride)

BR

Beeser Ramamoorthy LLP

Security for Costs Required before Proceeding Permitted to Move Forward (tellectual Property Weekly Abstracts Bulletin - Week of May 21, 2012)

BL

Borden Ladner Gervais LLP

Consultation On PMPRB Guidelines

Canada Healthcare

BL

Borden Ladner Gervais LLP

See more

Copyright

Coup d'œil sur les nouvelles règles de PIO concernant le financement des services juridiques en PI pour les entreprises de l'Ontario

En réponse directe aux commentaires reçus et à l'évolution des besoins des entreprises d'innovation de l'Ontario en matière de propriété intellectuelle, Propriété intellectuelle Ontario (PIO) a annoncé deux...

MT

Miller Thomson LLP

Technology Law: A Comprehensive Annual Review 2024-2025

On June 19, 2025, I had the pleasure of presenting my annual "Computer and IT Law: The Year in Review" to the Toronto Computer Lawyers Group.

Canada Technology

MT

McCarthy Tétrault LLP

Incidence de l'IA sur le droit canadien

L'évolution de la technologie de l'intelligence artificielle (« IA ») entraîne des changements considérables dans bien des secteurs au Canada...

BC

Blake, Cassels & Graydon LLP

IP Licensing Primer Part Three: Term And Termination

MA

MLT Aikins LLP

From Agriculture To Autos: What Right To Repair Means For Business

BJ

Bennett Jones LLP

The United States Trade Representative Criticizes Canada's IP Enforcement Regime

C

Cassels

Copyright In The Age Of AI: Legal Tensions And Emerging Cases

MA

MLT Aikins LLP

The YouTube-ification Of Canadian Copyright Law (Video)

PL

Procido LLP

IP Assets: A Guide To Maximizing Your Portfolio's Value

GW

Gowling WLG

See more

Licensing & Syndication

IP Licensing Primer Part Three: Term And Termination

In part one of our IP licensing primer series, we broached the concept of IP licensing and explained how the type of IP...

MA

MLT Aikins LLP

IP Assets: A Guide To Maximizing Your Portfolio's Value

Intellectual property is a key asset of most businesses, yet IP rights are often underutilized or misunderstood as a business asset.

GW

Gowling WLG

Licensing Partnerships In Life Sciences: Emerging And Expected Trends In 2025

With the year well underway, it's an opportune time to examine the emerging and expected trends in 2025 for licensing partnerships in the life sciences industry.

Canada Healthcare

GW

Gowling WLG

Celebrating World IP Day 2025

SB

Smart & Biggar

Mattel Reclaims DC Toys: A Plastic Resurrection Worthy Of A Reboot

NL

Nelligan Law

Sole Searching: Finding The Perfect Intellectual Property License

D

Dentons

Data Licensing: Best Practices For Licensing Your Business Data

Brion Raffoul

IP Licensing Primer Part Two: Reaping The Benefits

MA

MLT Aikins LLP

Intellectual Property Primer Part One: What Parties Should Know & Avoid During Licensing

MA

MLT Aikins LLP

See more

Patent

Coup d'œil sur les nouvelles règles de PIO concernant le financement des services juridiques en PI pour les entreprises de l'Ontario

En réponse directe aux commentaires reçus et à l'évolution des besoins des entreprises d'innovation de l'Ontario en matière de propriété intellectuelle, Propriété intellectuelle Ontario (PIO) a annoncé deux...

MT

Miller Thomson LLP

Update On Biosimilars In Canada – June 2025

This article provides an update on developments in the biosimilar space in Canada—regulatory, approvals, pending submissions, litigation, and market access—since our March 2024 update.

Canada Healthcare

SB

Smart & Biggar

Updated PMPRB Guidelines Expected In Summer 2025 And NPDUIS Releases Ninth Edition Of The Meds Entry Watch Report

In the Patented Medicine Prices Review Board (PMPRB)'s June 2025 NEWSletter, Acting Chairperson Anie Perrault confirms that the PMPRB plans on publishing its final Guidelines in summer 2025.

Canada Healthcare

SB

Smart & Biggar

Canadian Patent Law: A Board Assesses Patentability While The Court Assesses Validity

ML

McMillan LLP

Patents vs Trade Secrets In Canada – No, They're Not Just Alternatives

PL

Procido LLP

Inventorship And The Importance Of Invention Documentation

OW

Oyen Wiggs Green & Mutala LLP

Canadian Intellectual Property Office "Next Generation Patents" Update And Status As Of June 17, 2025

SB

Smart & Biggar

Potential Amendments To Canadian Practice On Patentable Subject-Matter For Computer-Implemented Inventions

C

Cassels

Incidence de l'IA sur le droit canadien

BC

Blake, Cassels & Graydon LLP

See more

Latest Videos

See more

The YouTube-ification Of Canadian Copyright Law (Video)

PL

Procido LLP

IP Explained: How To Use A Patent (Video)

FL

Field LLP

Law Talk Season 2 Episode 03: Business Law - Naming Your Business (Video)

FH

FH&P Lawyers

Getting Copyright Right For Generative AI (Video)

GW

Gowling WLG

Can AI Be An Inventor On A Patent Or Author Of A Copyrighted Work?

OH

Osler, Hoskin & Harcourt LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More